Latest Observability News

Page 8 of 165
Alara Resources delivered its strongest quarterly copper sales since commercial operations began, while production remained above nameplate capacity at its Oman mine. Yet the company says the parent may need to raise about A$6 million in FY27 to cover a projected cash shortfall.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Black Horse Mining has uncovered a previously unrecorded underground crosscut at Mt Egerton, where face samples returned more than 10 grams per tonne of gold over two narrow intervals. The discovery comes as a silenced drill rig begins testing the project, with A$4.41 million in cash supporting an estimated 5.46 quarters of funding.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Rapid Critical Metals has completed maiden drilling at its Prophet River gallium-germanium project, with visible sphalerite and galena logged in all seven holes. The strongest downhole intervals widened at Pad 2, but laboratory assays will determine whether the visual results contain economic zinc, germanium or gallium grades.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Hamelin Gold has reported an ultra-high-grade 2-metre interval grading 101.5 g/t gold from its Phase 2 drilling at Day Dawn, alongside extensions to the Aurora and Altus lodes. Further RC assays and diamond drilling results could provide the next test of how continuous and extensive the system is.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Viking Mines has confirmed significant tungsten mineralisation in all five assayed Linka Main holes, while advancing ore sorting, bulk sampling and processing plans in Nevada. The progress comes with no JORC resource yet defined and approximately 1.8 quarters of funding at current cash outflows.
Maxwell Dee
Maxwell Dee
26 Oct 2026
Accelerate Resources has begun maiden drilling at Gingarrigan, an untested prospect outside its existing Woodie Woodie North resource base, while securing A$1.1 million for exploration. The results will test whether surface manganese outcrops extend into a potentially broader mineralised system.
Maxwell Dee
Maxwell Dee
26 Oct 2026
Artrya has converted its largest US customer and first SAPPHIRE Study participant into a five-year commercial agreement, while delaying its planned Coronary Flow FDA submission to strengthen clinical evidence. The Salix rollout is gaining traction, but revenue remains early and scan volumes are undisclosed.
Victor Sage
Victor Sage
26 Oct 2026
Peregrine Gold has advanced a portfolio of Pilbara gold targets, from a 4km auriferous palaeogravel zone at Capricorn to high-grade rock-chip results at Pilgangoora North. A $2.25 million placement strengthens the near-term exploration program, although quarter-end cash covered less than one quarter of reported outgoings before the raising.
Maxwell Dee
Maxwell Dee
26 Oct 2026
New research from the NEPTUNE cohort has strengthened the biological rationale for Dimerix’s DMX-200 kidney drug, linking CCR2 activity and urinary MCP-1 levels with poorer outcomes in FSGS. The findings support the drug’s mechanism, but do not yet demonstrate Phase 3 efficacy.
Ada Torres
Ada Torres
23 Oct 2026
Eminence Minerals has exercised options to earn an initial 30% interest across five Côte d’Ivoire gold projects covering about 1,508 km². The interests remain subject to completion conditions, while the company prepares to lead exploration across 871 km² of granted tenure.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Arovella has released two clinical batches of its off-the-shelf CAR-iNKT therapy, activated two trial sites and begun screening patients ahead of expected first dosing in October. The biotech ended September with A$11.6 million in cash, rising to about A$15.63 million pro forma after an R&D rebate.
Ada Torres
Ada Torres
23 Oct 2026
Racura Oncology says both Phase 1 RC220 programs have cleared their opening dose cohorts without dose-limiting toxicities, while its Korean expansion broadens the CPACS trial. The company ended September with $30.7 million in cash, which management says funds committed activities into mid-2028.
Victor Sage
Victor Sage
22 Oct 2026

Browse the archive

Full archive